The clinical decision support systems market would grow at a CAGR of 9.45% over the predicted time frame. The market is expected to increase in value from US$ 6.02 Bn in 2022 to US$ 12.4 Bn in 2030.
The on clinical decision support systems Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2237
A recent report provides crucial insights along with application based and forecast information in the Global Clinical decision support systems Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Clinical decision support systems market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Clinical decision support systems market are included as given below:
Clinical decision support systems Market Key Players are: McKesson Corporation, IBM Corporation, Siemens Healthineers GmbH, NextGen Healthcare Inc., Cerner Corporation, Agfa-Gevaert Group, Wolters Kluwer N.V., Koninklijke Philips N.V. (Royal Philips), Allscripts Healthcare, LLC, athenahealth, Inc.
Market Segments
By Product
- Standalone CDSS
- Integrated CPOE
- Integrated E.H.R
- Integrated CDSS with CPOE & E.H.R.
By Application
- Drug Allergy Alerts
- Clinical Guidelines
- Drug-drug Interactions
- Clinical Reminders
- Drug Dosing Support
- Others
By Delivery Mode
- On-premise Systems
- Web-based Systems
- Cloud-based Systems
By Component
- Hardware
- Software
- Services
By Model
- Knowledge based
- Non-Knowledge based
By Type
- Therapeutic
- Diagnostic
By Level of Interactivity
- Active CDSS
- Passive CDSS
By Settings
- In Patient
- Ambulatory care settings
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global clinical decision support systems market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the clinical decision support systems market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Clinical Decision Support Systems Market, By Product
7.1. Clinical Decision Support Systems Market, by Product, 2022-2030
7.1.1. Standalone CDSS
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Integrated CPOE
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Integrated E.H.R
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Integrated CDSS with CPOE & E.H.R.
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Clinical Decision Support Systems Market, By Application
8.1. Clinical Decision Support Systems Market, by Application, 2022-2030
8.1.1. Drug Allergy Alerts
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Clinical Guidelines
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Drug-drug Interactions
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Clinical Reminders
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Drug Dosing Support
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Clinical Decision Support Systems Market, By Delivery Mode
9.1. Clinical Decision Support Systems Market, by Delivery Mode, 2022-2030
9.1.1. On-premise Systems
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Web-based Systems
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Cloud-based Systems
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Clinical Decision Support Systems Market, By Component
10.1. Clinical Decision Support Systems Market, by Component, 2022-2030
10.1.1. Hardware
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Software
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Services
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Clinical Decision Support Systems Market, By Model
11.1. Clinical Decision Support Systems Market, by Model, 2022-2030
11.1.1. Knowledge based
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Non-Knowledge based
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Clinical Decision Support Systems Market, By Type
12.1. Clinical Decision Support Systems Market, by Type, 2022-2030
12.1.1. Therapeutic
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Diagnostic
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Clinical Decision Support Systems Market, By Level of Interactivity
13.1. Clinical Decision Support Systems Market, by Level of Interactivity, 2022-2030
13.1.1. Active CDSS
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Passive CDSS
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Clinical Decision Support Systems Market, By Settings
14.1. Clinical Decision Support Systems Market, by Settings, 2022-2030
14.1.1. In Patient
14.1.1.1. Market Revenue and Forecast (2017-2030)
14.1.2. Ambulatory care settings
14.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 15. Global Clinical Decision Support Systems Market, Regional Estimates and Trend Forecast
15.1. North America
15.1.1. Market Revenue and Forecast, by Product (2017-2030)
15.1.2. Market Revenue and Forecast, by Application (2017-2030)
15.1.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.1.4. Market Revenue and Forecast, by Component (2017-2030)
15.1.5. Market Revenue and Forecast, by Model (2017-2030)
15.1.6. Market Revenue and Forecast, by Type (2017-2030)
15.1.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.1.8. Market Revenue and Forecast, by Settings (2017-2030)
15.1.9. U.S.
15.1.9.1. Market Revenue and Forecast, by Product (2017-2030)
15.1.9.2. Market Revenue and Forecast, by Application (2017-2030)
15.1.9.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.1.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.1.9.5. Market Revenue and Forecast, by Model (2017-2030)
15.1.9.6. Market Revenue and Forecast, by Type (2017-2030)
15.1.9.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.1.9.8. Market Revenue and Forecast, by Settings (2017-2030)
15.1.10. Rest of North America
15.1.10.1. Market Revenue and Forecast, by Product (2017-2030)
15.1.10.2. Market Revenue and Forecast, by Application (2017-2030)
15.1.10.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.1.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.1.10.5. Market Revenue and Forecast, by Model (2017-2030)
15.1.10.6. Market Revenue and Forecast, by Type (2017-2030)
15.1.10.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.1.10.8. Market Revenue and Forecast, by Settings (2017-2030)
15.2. Europe
15.2.1. Market Revenue and Forecast, by Product (2017-2030)
15.2.2. Market Revenue and Forecast, by Application (2017-2030)
15.2.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.2.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.5. Market Revenue and Forecast, by Model (2017-2030)
15.2.6. Market Revenue and Forecast, by Type (2017-2030)
15.2.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.2.8. Market Revenue and Forecast, by Settings (2017-2030)
15.2.9. UK
15.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
15.2.9.2. Market Revenue and Forecast, by Application (2017-2030)
15.2.9.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.2.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.9.5. Market Revenue and Forecast, by Model (2017-2030)
15.2.9.6. Market Revenue and Forecast, by Type (2017-2030)
15.2.9.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.2.9.8. Market Revenue and Forecast, by Settings (2017-2030)
15.2.10. Germany
15.2.10.1. Market Revenue and Forecast, by Product (2017-2030)
15.2.10.2. Market Revenue and Forecast, by Application (2017-2030)
15.2.10.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.2.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.10.5. Market Revenue and Forecast, by Model (2017-2030)
15.2.10.6. Market Revenue and Forecast, by Type (2017-2030)
15.2.10.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.2.10.8. Market Revenue and Forecast, by Settings (2017-2030)
15.2.11. France
15.2.11.1. Market Revenue and Forecast, by Product (2017-2030)
15.2.11.2. Market Revenue and Forecast, by Application (2017-2030)
15.2.11.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.2.11.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.11.5. Market Revenue and Forecast, by Model (2017-2030)
15.2.11.6. Market Revenue and Forecast, by Type (2017-2030)
15.2.11.7. Market Revenue and Forecast, by Settings (2017-2030)
15.2.11.8. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.2.12. Rest of Europe
15.2.12.1. Market Revenue and Forecast, by Product (2017-2030)
15.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
15.2.12.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.2.12.4. Market Revenue and Forecast, by Component (2017-2030)
15.2.12.5. Market Revenue and Forecast, by Model (2017-2030)
15.2.12.6. Market Revenue and Forecast, by Type (2017-2030)
15.2.12.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.2.12.8. Market Revenue and Forecast, by Settings (2017-2030)
15.3. APAC
15.3.1. Market Revenue and Forecast, by Product (2017-2030)
15.3.2. Market Revenue and Forecast, by Application (2017-2030)
15.3.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.3.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.5. Market Revenue and Forecast, by Model (2017-2030)
15.3.6. Market Revenue and Forecast, by Type (2017-2030)
15.3.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.3.8. Market Revenue and Forecast, by Settings (2017-2030)
15.3.9. India
15.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
15.3.9.2. Market Revenue and Forecast, by Application (2017-2030)
15.3.9.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.3.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.9.5. Market Revenue and Forecast, by Model (2017-2030)
15.3.9.6. Market Revenue and Forecast, by Type (2017-2030)
15.3.9.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.3.9.8. Market Revenue and Forecast, by Settings (2017-2030)
15.3.10. China
15.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
15.3.10.2. Market Revenue and Forecast, by Application (2017-2030)
15.3.10.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.3.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.10.5. Market Revenue and Forecast, by Model (2017-2030)
15.3.10.6. Market Revenue and Forecast, by Type (2017-2030)
15.3.10.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.3.10.8. Market Revenue and Forecast, by Settings (2017-2030)
15.3.11. Japan
15.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
15.3.11.2. Market Revenue and Forecast, by Application (2017-2030)
15.3.11.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.3.11.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.11.5. Market Revenue and Forecast, by Model (2017-2030)
15.3.11.6. Market Revenue and Forecast, by Type (2017-2030)
15.3.11.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.3.11.8. Market Revenue and Forecast, by Settings (2017-2030)
15.3.12. Rest of APAC
15.3.12.1. Market Revenue and Forecast, by Product (2017-2030)
15.3.12.2. Market Revenue and Forecast, by Application (2017-2030)
15.3.12.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.3.12.4. Market Revenue and Forecast, by Component (2017-2030)
15.3.12.5. Market Revenue and Forecast, by Model (2017-2030)
15.3.12.6. Market Revenue and Forecast, by Type (2017-2030)
15.3.12.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.3.12.8. Market Revenue and Forecast, by Settings (2017-2030)
15.4. MEA
15.4.1. Market Revenue and Forecast, by Product (2017-2030)
15.4.2. Market Revenue and Forecast, by Application (2017-2030)
15.4.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.4.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.5. Market Revenue and Forecast, by Model (2017-2030)
15.4.6. Market Revenue and Forecast, by Type (2017-2030)
15.4.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.4.8. Market Revenue and Forecast, by Settings (2017-2030)
15.4.9. GCC
15.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
15.4.9.2. Market Revenue and Forecast, by Application (2017-2030)
15.4.9.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.4.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.9.5. Market Revenue and Forecast, by Model (2017-2030)
15.4.9.6. Market Revenue and Forecast, by Type (2017-2030)
15.4.9.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.4.9.8. Market Revenue and Forecast, by Settings (2017-2030)
15.4.10. North Africa
15.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
15.4.10.2. Market Revenue and Forecast, by Application (2017-2030)
15.4.10.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.4.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.10.5. Market Revenue and Forecast, by Model (2017-2030)
15.4.10.6. Market Revenue and Forecast, by Type (2017-2030)
15.4.10.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.4.10.8. Market Revenue and Forecast, by Settings (2017-2030)
15.4.11. South Africa
15.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
15.4.11.2. Market Revenue and Forecast, by Application (2017-2030)
15.4.11.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.4.11.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.11.5. Market Revenue and Forecast, by Model (2017-2030)
15.4.11.6. Market Revenue and Forecast, by Type (2017-2030)
15.4.11.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.4.11.8. Market Revenue and Forecast, by Settings (2017-2030)
15.4.12. Rest of MEA
15.4.12.1. Market Revenue and Forecast, by Product (2017-2030)
15.4.12.2. Market Revenue and Forecast, by Application (2017-2030)
15.4.12.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.4.12.4. Market Revenue and Forecast, by Component (2017-2030)
15.4.12.5. Market Revenue and Forecast, by Model (2017-2030)
15.4.12.6. Market Revenue and Forecast, by Type (2017-2030)
15.4.12.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.4.12.8. Market Revenue and Forecast, by Settings (2017-2030)
15.5. Latin America
15.5.1. Market Revenue and Forecast, by Product (2017-2030)
15.5.2. Market Revenue and Forecast, by Application (2017-2030)
15.5.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.5.4. Market Revenue and Forecast, by Component (2017-2030)
15.5.5. Market Revenue and Forecast, by Model (2017-2030)
15.5.6. Market Revenue and Forecast, by Type (2017-2030)
15.5.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.5.8. Market Revenue and Forecast, by Settings (2017-2030)
15.5.9. Brazil
15.5.9.1. Market Revenue and Forecast, by Product (2017-2030)
15.5.9.2. Market Revenue and Forecast, by Application (2017-2030)
15.5.9.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.5.9.4. Market Revenue and Forecast, by Component (2017-2030)
15.5.9.5. Market Revenue and Forecast, by Model (2017-2030)
15.5.9.6. Market Revenue and Forecast, by Type (2017-2030)
15.5.9.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.5.9.8. Market Revenue and Forecast, by Settings (2017-2030)
15.5.10. Rest of LATAM
15.5.10.1. Market Revenue and Forecast, by Product (2017-2030)
15.5.10.2. Market Revenue and Forecast, by Application (2017-2030)
15.5.10.3. Market Revenue and Forecast, by Delivery Mode (2017-2030)
15.5.10.4. Market Revenue and Forecast, by Component (2017-2030)
15.5.10.5. Market Revenue and Forecast, by Model (2017-2030)
15.5.10.6. Market Revenue and Forecast, by Type (2017-2030)
15.5.10.7. Market Revenue and Forecast, by Level of Interactivity (2017-2030)
15.5.10.8. Market Revenue and Forecast, by Settings (2017-2030)
Chapter 16. Company Profiles
16.1. McKesson Corporation
16.1.1. Company Overview
16.1.2. Product Offerings
16.1.3. Financial Performance
16.1.4. Recent Initiatives
16.2. IBM Corporation
16.2.1. Company Overview
16.2.2. Product Offerings
16.2.3. Financial Performance
16.2.4. Recent Initiatives
16.3. Siemens Healthineers GmbH
16.3.1. Company Overview
16.3.2. Product Offerings
16.3.3. Financial Performance
16.3.4. Recent Initiatives
16.4. NextGen Healthcare Inc.
16.4.1. Company Overview
16.4.2. Product Offerings
16.4.3. Financial Performance
16.4.4. Recent Initiatives
16.5. Cerner Corporation
16.5.1. Company Overview
16.5.2. Product Offerings
16.5.3. Financial Performance
16.5.4. Recent Initiatives
16.6. Agfa-Gevaert Group
16.6.1. Company Overview
16.6.2. Product Offerings
16.6.3. Financial Performance
16.6.4. Recent Initiatives
16.7. Wolters Kluwer N.V.
16.7.1. Company Overview
16.7.2. Product Offerings
16.7.3. Financial Performance
16.7.4. Recent Initiatives
16.8. Koninklijke Philips N.V. (Royal Philips)
16.8.1. Company Overview
16.8.2. Product Offerings
16.8.3. Financial Performance
16.8.4. Recent Initiatives
16.9. Allscripts Healthcare
16.9.1. Company Overview
16.9.2. Product Offerings
16.9.3. Financial Performance
16.9.4. Recent Initiatives
16.10. LLC
16.10.1. Company Overview
16.10.2. Product Offerings
16.10.3. Financial Performance
16.10.4. Recent Initiatives
Chapter 17. Research Methodology
16.7. Primary Research
16.7. Secondary Research
16.7. Assumptions
Chapter 18. Appendix
18.1. About Us
18.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments